Long-Reads Sequencing Strategy to Localize Variants in TTN Repeated Domains.


Journal

The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612

Informations de publication

Date de publication:
07 2022
Historique:
received: 17 02 2022
revised: 23 03 2022
accepted: 18 04 2022
pubmed: 18 5 2022
medline: 8 7 2022
entrez: 17 5 2022
Statut: ppublish

Résumé

Titin protein is responsible for muscle elasticity. The TTN gene, composed of 364 exons, is subjected to extensive alternative splicing and leads to different isoforms expressed in skeletal and cardiac muscle. Variants in TTN are responsible for myopathies with a wide phenotypic spectrum and autosomal dominant or recessive transmission. The I-band coding domain, highly subject to alternative splicing, contains a three-zone block of repeated sequences with 99% homology. Sequencing and localization of variants in these areas are complex when using short-reads sequencing, a second-generation sequencing technique. We have implemented a protocol based on the third-generation sequencing technology (long-reads sequencing). This new method allows us to localize variants in these repeated areas to improve the diagnosis of TTN-related myopathies and offer the analysis of relatives in postnatal or in prenatal screening.

Identifiants

pubmed: 35580751
pii: S1525-1578(22)00131-3
doi: 10.1016/j.jmoldx.2022.04.006
pii:
doi:

Substances chimiques

Connectin 0
Protein Isoforms 0
TTN protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-726

Informations de copyright

Copyright © 2022 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Aurélien Perrin (A)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.

Charles Van Goethem (C)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France.

Corinne Thèze (C)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France.

Jacques Puechberty (J)

Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier, France.

Thomas Guignard (T)

Laboratoire de Génétique Chromosomique, Plateforme ChromoStem, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Bérénice Lecardonnel (B)

Laboratoire de Génétique Chromosomique, Plateforme ChromoStem, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Delphine Lacourt (D)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France.

Corinne Métay (C)

Assistance Publique-Hôpitaux de Paris (AP-HP), UF Molecular Cardiogenetics and Myogenetics, Sorbonne Université and Sorbonne Université UPMC Paris 06-Inserm UMRS974, Research Center in Myology, Pitié-Salpêtrière Hospital, Paris, France.

Arnaud Isapof (A)

Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile de France, Service de Neuropédiatrie, Hôpital Trousseau, Paris, France.

Sandra Whalen (S)

Genetics and Cytogenetics Department, Centre de Référence Déficiences Intellectuelles de Causes Rares, Pitié-Salpétrière, AP-HP, Paris, France.

Ana Ferreiro (A)

AP-HP, Centre de Référence des Pathologies Neuromusculaires Nord-Est-Ile de France, Institut de Myologie, GHU Pitié-Salpêtrière, Paris, France; Basic and Translational Myology Laboratory, Université de Paris BFA, UMR 8251, CNRS, Paris, France.

Marie-Christine Arne-Bes (MC)

Department of Neurology, Purpan University Hospital, Toulouse, France.

Susana Quijano-Roy (S)

AP-HP, GH Université Paris-Saclay, Neuromuscular Center, Child Neurology and ICU Department, Raymond Poincare Hospital, Garches, France; Université de Versailles, U1179 INSERM-UVSQ, Montigny, France.

Juliette Nectoux (J)

Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, AP-HP, Centre-Université de Paris, Paris, France.

France Leturcq (F)

Department of Genetics and Molecular Biology, AP-HP, Cochin Hospital, Paris, France.

Pascale Richard (P)

Assistance Publique-Hôpitaux de Paris (AP-HP), UF Molecular Cardiogenetics and Myogenetics, Sorbonne Université and Sorbonne Université UPMC Paris 06-Inserm UMRS974, Research Center in Myology, Pitié-Salpêtrière Hospital, Paris, France.

Marion Larrieux (M)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France.

Anne Bergougnoux (A)

PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.

Franck Pellestor (F)

Laboratoire de Génétique Chromosomique, Plateforme ChromoStem, CHU de Montpellier, Université de Montpellier, Montpellier, France.

Michel Koenig (M)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.

Mireille Cossée (M)

Molecular Diagnostic Laboratory, Montpellier University Hospital, Montpellier, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France. Electronic address: mireille.cossee@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH